Epidemiology, Clinical Characteristics, and Temporal Patterns of Thrombosis Following Vaccination: A 35-Year Analysis of the Vaccine Adverse Event Reporting System, 1990–2025

Abstract Introduction: Thrombosis is an uncommon but clinically important adverse event following vaccination because of its potential for serious morbidity and mortality. Although concerns increased during the coronavirus disease 2019 (COVID-19) vaccination era, comprehensive analyses of thrombosis reports in the Vaccine Adverse Event Reporting System (VAERS) remain limited. Aim: To analyze thrombosis reports submitted to VAERS between 1990 and 2025 and evaluate demographic characteristics, vaccine associations, onset intervals, clinical outcomes, and differences between serious and nonserious reports. Methods: A retrospective observational study was conducted using publicly available VAERS data extracted in May 2026. Reports containing the adverse event term “thrombosis” from 1990 to 2025 were analyzed. Variables included age, sex, vaccine type, onset interval, clinical outcomes, and seriousness classification. Descriptive statistics and Chi-square or Fisher’s exact tests were used. Results: A total of 5565 thrombosis reports were identified, including 2398 (43.1%) serious reports. Females accounted for 59.3% of reports, whereas males were overrepresented in serious cases. Serious outcomes were more common among adults aged ≥65 years. COVID-19 vaccines accounted for the largest proportion of reports. Most documented cases occurred within 1–3 days of vaccination. Hospitalization (33.1%), life-threatening events (17.8%), and death (6.2%) were the most frequent outcomes. Significant differences were observed for age, sex, vaccine type, and onset interval (all P ≤ 0.05). Conclusion: Thrombosis reports showed distinct demographic and clinical patterns, supporting continued postmarketing pharmacovigilance while acknowledging the limitations of passive surveillance in establishing causality.

Authors

Institutions

Publication Details

Journal
Annals of African Medicine
Published
2026-11-16
DOI
https://doi.org/10.4103/aam.aam_1129_26
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Epidemiology, Clinical Characteristics, and Temporal Patterns of Thrombosis Following Vaccination: A 35-Year Analysis of the Vaccine Adverse Event Reporting System, 1990–2025

Ayush BHATTACHARJEE, Tanisha Jindal, Teshika Yalla, Vineesha Divakar Reddy
Annals of African Medicine
Pharmacovigilance and Adverse Drug Reactions
article

Epidemiology, Clinical Characteristics, and Temporal Patterns of Thrombosis Following Vaccination: A 35-Year Analysis of the Vaccine Adverse Event Reporting System, 1990–2025

Ayush BHATTACHARJEE, Tanisha Jindal, Teshika Yalla, Vineesha Divakar Reddy
article en

Abstract

Abstract Introduction: Thrombosis is an uncommon but clinically important adverse event following vaccination because of its potential for serious morbidity and mortality. Although concerns increased during the coronavirus disease 2019 (COVID-19) vaccination era, comprehensive analyses of thrombosis reports in the Vaccine Adverse Event Reporting System (VAERS) remain limited. Aim: To analyze thrombosis reports submitted to VAERS between 1990 and 2025 and evaluate demographic characteristics, vaccine associations, onset intervals, clinical outcomes, and differences between serious and nonserious reports. Methods: A retrospective observational study was conducted using publicly available VAERS data extracted in May 2026. Reports containing the adverse event term “thrombosis” from 1990 to 2025 were analyzed. Variables included age, sex, vaccine type, onset interval, clinical outcomes, and seriousness classification. Descriptive statistics and Chi-square or Fisher’s exact tests were used. Results: A total of 5565 thrombosis reports were identified, including 2398 (43.1%) serious reports. Females accounted for 59.3% of reports, whereas males were overrepresented in serious cases. Serious outcomes were more common among adults aged ≥65 years. COVID-19 vaccines accounted for the largest proportion of reports. Most documented cases occurred within 1–3 days of vaccination. Hospitalization (33.1%), life-threatening events (17.8%), and death (6.2%) were the most frequent outcomes. Significant differences were observed for age, sex, vaccine type, and onset interval (all P ≤ 0.05). Conclusion: Thrombosis reports showed distinct demographic and clinical patterns, supporting continued postmarketing pharmacovigilance while acknowledging the limitations of passive surveillance in establishing causality.

Annals of African Medicine
Topiwala National Medical College & BYL Nair Charitable Hospital (IN), Sri Venkateswara Medical College and Ruia Hospital (IN), National Institute of Mental Health and Neurosciences (IN)
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon